Everything you need to know about semaglutide and GLP-1 medications — from the science behind them to practical guides on dosing, side effects, costs, and provider comparisons.
Last Updated: 21 March 2026
The Science of GLP-1 Receptor Agonists
GLP-1 (glucagon-like peptide-1) receptor agonists mimic a naturally occurring gut hormone that regulates blood sugar and appetite. When you eat, GLP-1 is released from intestinal cells, stimulating insulin secretion, slowing gastric emptying, and sending satiety signals to the brain. Semaglutide is a synthetic analogue of this hormone, engineered to have a longer half-life than natural GLP-1 — allowing once-weekly dosing.
→ Semaglutide for Weight Loss: Complete Guide for 2026
→ How Peptides Work: A Beginner-Friendly Explanation
Semaglutide Basics
Dosing schedules, administration, what to expect. Semaglutide is available as a subcutaneous injection (Wegovy, Ozempic) and as an oral tablet (Rybelsus). Doses are titrated gradually over several months to minimise side effects and allow the body to adjust.
→ Semaglutide Dosing Schedule: Titration Guide Explained
→ Semaglutide Injection Guide: How to Self-Administer Safely
→ Oral Semaglutide (Rybelsus) vs Injectable: Comparison
→ Semaglutide Weight Loss Timeline: Week by Week Results
Other GLP-1 Medications
Comparing Wegovy, Ozempic, Mounjaro, Saxenda. While semaglutide dominates headlines, it’s one of several GLP-1 medications available in the UK. Each has different dosing frequencies, approved indications, and cost profiles.
→ Wegovy vs Ozempic: Which Is Better for Weight Loss?
→ Tirzepatide (Mounjaro) vs Semaglutide: Head-to-Head Comparison
→ Semaglutide vs Saxenda: Which GLP-1 Medication Is More Effective?
→ Future GLP-1 Medications: What’s Coming After Semaglutide
Side Effects and Safety
What the clinical trials show and real-world experiences. The STEP trial programme demonstrated that semaglutide (2.4mg weekly) produces significant weight loss, but also reported common gastrointestinal side effects including nausea, vomiting, and diarrhoea — particularly during dose escalation.
→ Semaglutide Side Effects: What to Expect and How to Manage
→ Long-Term Safety of Semaglutide: What Research Shows
→ Semaglutide Side Effects First Month: What to Expect in 2026
→ Semaglutide and Pregnancy: Important Safety Information
Peptide Therapy
BPC-157, TB-500, and therapeutic peptides. Beyond GLP-1 medications, the field of peptide therapy encompasses a range of compounds being researched for tissue repair, cognitive function, and metabolic health. BPC-157 and TB-500 (Thymosin Beta-4) are among the most studied.
→ Thymosin Beta-4 Peptide: Tissue Repair and Regeneration Research
→ Peptide Therapy for Joint Pain: Which Peptides Actually Help
→ How NAD+ Peptides Support Weight Management Naturally 2026
→ The Future of Peptide Medicine: What Clinical Trials Are Showing
Diet and Lifestyle on GLP-1 Medications
Nutrition, exercise, and practical tips. GLP-1 medications work best when combined with healthy lifestyle changes. Appetite suppression is a powerful tool, but optimising what you eat and how you move can significantly enhance results.
→ Best Diet to Follow While Taking Semaglutide
→ Semaglutide and Exercise: Optimizing Your Results
→ Best Low-Carb Meal Plans to Pair with Semaglutide
→ Guide to Combining Semaglutide with Intermittent Fasting Safely
Cost and Access
UK pricing, NHS availability, private options. Semaglutide for weight loss (Wegovy) is available on the NHS through specialist weight management services, but access remains limited by eligibility criteria and service capacity. Most patients currently access it privately.
→ Semaglutide Cost in the UK: NHS vs Private Prescriptions
→ How to Get a Semaglutide Prescription UK NHS 2026
→ Best Online Clinics for Semaglutide Prescriptions in the UK
→ Best GLP-1 Weight Loss Programs UK: 2026 Comparison Guide
FAQ
How does semaglutide cause weight loss?
Semaglutide activates GLP-1 receptors in the brain, particularly in the hypothalamus, reducing appetite and food cravings. It also slows gastric emptying, meaning food stays in your stomach longer, prolonging feelings of fullness. Clinical trials show average weight loss of 15–17% of body weight over 68 weeks at the 2.4mg weekly dose.
Is semaglutide available on the NHS?
Wegovy (semaglutide 2.4mg) is approved for NHS use in England for adults with a BMI of 35+ and at least one weight-related condition. However, NHS access is currently limited to specialist weight management services and is being rolled out gradually. Most people access it privately through online clinics.
What are the most common side effects of semaglutide?
The most frequently reported side effects are gastrointestinal: nausea, vomiting, diarrhoea, and constipation. These are most common during dose escalation and typically improve over time. Serious side effects are rare but include pancreatitis and gallbladder problems. Always consult a prescriber before starting treatment.
How long do you need to take semaglutide?
Current evidence suggests that weight regain occurs after stopping semaglutide — on average, patients regain about two-thirds of lost weight within a year of discontinuation. This suggests long-term or indefinite use may be required for sustained benefit, similar to other chronic disease medications.
Explore Our Full Library
Our growing library of evidence-based guides covers every aspect of semaglutide, GLP-1 therapy, peptide treatments, and metabolic health. Whether you’re just starting your research or looking for specific clinical details, you’ll find it here.
→ How Much Weight Can You Lose on Semaglutide?
→ Semaglutide Before and After: Real Patient Results
→ How Long Do You Need to Take Semaglutide for Weight Loss?
→ My 6-Month Semaglutide Journey — What No One Tells You Before Starting